Plain-English translation of NCT05117424 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Coronary Artery Disease research guide โThe CAMPUS study is following 3,000 patients who have coronary artery disease (blocked or narrowed arteries in the heart) along with metabolic problems like diabetes, obesity, or kidney disease. Researchers want to understand how these conditions interact and affect artery health. By tracking participants over time, the study aims to identify which factors most strongly influence how the disease progresses.
Many patients have both heart disease and metabolic disorders at the same time, but doctors don't fully understand how these conditions affect each other. This study exists to fill that gap and help doctors better predict and manage disease progression in patients with multiple conditions.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
As a participant, you would share your health information and medical records with the research team. The study is observational, meaning researchers will follow your health over time and monitor how your conditions progress, but you won't receive an experimental medication. You'll likely have regular clinic visits where your doctors will track your symptoms, run tests, and collect data about your health status.
AI-generated summary from trial data ยท Jun 1, 2026 ยท Not medical advice
China
Sponsor
Ruijin Hospital
Enrollment target
~3,000 participants
Started
January 2017
Primary completion
December 2025
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
18 Years โ 80 Years
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Xiaoqun Wang, M.D., Ph.D.
Ruijin Hospital, Shanghai Jiaotong School of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.